Abstract:Ethnopharmacological relevance: Chronic pain management represents a serious healthcare problem worldwide. The use of opioid analgesics for pain has always been hampered by their side effects; in particular, the addictive liability associated with chronic use. Finding a morphine replacement has been a long-standing goal in the field of analgesia. In traditional Chinese medicine, processed Buthus martensii Karsch (BmK) scorpion has been used as a painkiller to treat chronic inflammatory arthritis and spondylitis, so called "Scorpio-analgesia". However, the molecular basis and the underline mechanism for the Scorpio-analgesia are still unclear. Aim of the study: The study aims to investigate the molecular basis of "Scorpio analgesia" and identify novel analgesics from BmK scorpion. Materials and methods: In this study, the analgesic abilities were determined using formalin-, acetic acid-and complete Freund's adjuvant-induced pain models. The effect of BmK venom and processed BmK venom on Nav1.7 were detected by whole-cell voltage-clamp recordings on HEK293-hNav1.7 stable cell line. Action potentials in Dorsal root ganglion (DRG) neurons induced by Makatoxin-3-R58A were recorded in current-clamp mode. The content of Makatoxin-3 was detected using competitive enzyme-linked immunosorbent assay based on the Makatoxin-3 antibody. High performance liquid chromatography, western blot and circular dichroism spectroscopy were used to analysis the stability of Makatoxin-3. Results: Here we demonstrate that Makatoxin-3, an alpha-like toxin in BmK scorpion venom targeting Nav1.7 is the critical component in Scorpio-analgesia. The analgesic effect of Makatoxin-3 could not be reversed by naloxone and is more potent than Nav1.7-selective inhibitors and non-steroidal anti-inflammatory drugs in inflammatory models. Moreover, a R58A mutant of Makatoxin-3 is capable of eliciting analgesia effect without inducing pain response. Conclusions: This study advances ion channel biology and proposes Nav1.7 agonists, rather than the presumed Nav1.7-only blockers, for non-narcotic relief of chronic pain.

A Novel Scorpion Toxin Blocking Small Conductance Ca2+ Activated K+ Channel

BmBKTx1, a Novel Ca2+-activated K+ Channel Blocker Purified from the Asian Scorpion Buthus Martensi Karsch.

Molecular cloning, genomic organization and functional characterization of a new short-chain potassium channel toxin-like peptide BmTxKS4 from Buthus martensii Karsch(BmK)

Solution structure of BmKK2, a new potassium channel blocker from the venom of chinese scorpion Buthus martensi Karsch

Solution Structure of BmBKTx1, a New BKCa1Channel Blocker from the Chinese ScorpionButhus Martensikarsch,

BmP09, a “long Chain” Scorpion Peptide Blocker of BK Channels*

A potent potassium channel blocker from Mesobuthus eupeus scorpion venom

A Bimodal Activation Mechanism Underlies Scorpion Toxin-Induced Pain.

Effects of BmKNJX11, a Bioactive Polypeptide Purified from Buthus Martensi Karsch, on Sodium Channels in Rat Dorsal Root Ganglion Neurons.

Molecular Cloning and Analysis of BmKBT Genomic Sequence from Scorpion Buthus martensii Karsch

Makatoxin-3, a Thermostable Nav1.7 Agonist from Buthus Martensii Karsch (bmk) Scorpion Elicits Non-Narcotic Analgesia in Inflammatory Pain Models.

Different pharmacological properties between scorpion toxin BmKcug2 and its degraded analogs highlight the diversity of K+ channel blockers from thermally processed scorpions

Martentoxin, a Novel K+‐channel‐blocking Peptide: Purification, Cdna and Genomic Cloning, and Electrophysiological and Pharmacological Characterization

Molecular Cloning and Functional Expression of A Gene Encoding an Antiarrhythmia Peptide Derived from the Scorpion Toxin

Molecular Information of Charybdotoxin Blockade in the Large Conductance Calcium-activated Potassium Channel

Structure Of The Scorpion Toxin Bmbkttx1 Solved From Single Wavelength Anomalous Scattering Of Sulfur

Solid phase synthesis, NMR structure determination of α-KTx3.8, its in silico docking to Kv1.x potassium channels, and electrophysiological analysis provide insights into toxin-channel selectivity

Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus

Expression, Purification and Functional Characterization of a Recombinant Scorpion Venom Peptide BmTXKβ

Engineering a Peptide Inhibitor Towards the KCNQ1/KCNE1 Potassium Channel (Iks)

Structural basis for the voltage-gated Na+ channel selectivity of the scorpion alpha-like toxin BmK M1.